EUVIMEDEUVIMED entdecken
Crossref

26-A-15987-ACC UTILIZATION OF PCSK9 INHIBITORS AFTER MYOCARDIAL INFARCTION: INSIGHTS FROM A NATIONWIDE REAL-WORLD COHORT

Bilawal Nadeem, Koravich Lorlowhakarn, Johnny Bou Saba, Saad Ur Rahman, Sourbha S. Dani

JACC · 2026-04 · 87 (13) · A278

DOI: 10.1016/j.jacc.2026.02.690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Bilawal Nadeem und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nadeem, B., Lorlowhakarn, K., Saba, J. B., Rahman, S. U., & Dani, S. S. (2026). 26-A-15987-ACC UTILIZATION OF PCSK9 INHIBITORS AFTER MYOCARDIAL INFARCTION: INSIGHTS FROM A NATIONWIDE REAL-WORLD COHORT. JACC, 87(13), A278. https://doi.org/10.1016/j.jacc.2026.02.690

Vancouver

Nadeem B, Lorlowhakarn K, Saba JB, Rahman SU, Dani SS. 26-A-15987-ACC UTILIZATION OF PCSK9 INHIBITORS AFTER MYOCARDIAL INFARCTION: INSIGHTS FROM A NATIONWIDE REAL-WORLD COHORT. JACC. 2026;87(13):A278. doi:10.1016/j.jacc.2026.02.690

BibTeX
@article{Nadeem2026,
  author = {Nadeem, Bilawal and Lorlowhakarn, Koravich and Saba, Johnny Bou and Rahman, Saad Ur and Dani, Sourbha S.},
  title = {26-A-15987-ACC UTILIZATION OF PCSK9 INHIBITORS AFTER MYOCARDIAL INFARCTION: INSIGHTS FROM A NATIONWIDE REAL-WORLD COHORT},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A278},
  doi = {10.1016/j.jacc.2026.02.690}
}
Kostenlos starten →